Position in LH
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$977,480
-$112,172 QoQ
Shares Held
3,491
-14.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#470
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Resonant Capital Advisors, LLC holds $4,028,667 across 6 Diagnostics & Research names. LH ranks #3 (24.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
6,027 | $1,148,022 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
2,289 | $1,147,613 | |
| 3 | LH |
Labcorp Holdings Inc.
This page
|
3,491 | $977,480 | |
| 4 | WAT |
Waters Corp /De/
|
897 | $336,410 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
1,100 | $212,542 | |
| 6 | ILMN |
Illumina, Inc.
|
1,175 | $206,600 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $977,480 | 3,491 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $1,089,652 | 4,084 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $946,570 | 3,773 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $1,043,463 | 3,635 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $952,123 | 3,627 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $812,960 | 3,493 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $789,319 | 3,442 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $761,619 | 3,408 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $686,235 | 3,372 | Shares | Sole | 2024-08-01 | |
| No filing history on record for this holder in this stock. | ||||||